NCT05098210
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Bronchial Neoplasms, Carcinoma, Bronchogenic, +46 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Recurrent Mucosal Melanoma
Explore clinical trials studying Recurrent Mucosal Melanoma. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Recurrent Mucosal Melanoma trial results
Active, Not Recruiting
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
NCT02506153
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma, +18 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Virginia G Piper Cancer Care-Del Camino Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Active, Not Recruiting
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
NCT05111574
- Conditions
- Anal Melanoma, Bladder Melanoma, Cervical Melanoma, +14 more
- Locations
-
- Sutter Auburn Faith Hospital Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
- Palo Alto Medical Foundation-Fremont Fremont, California, United States
- Keck Medicine of USC Koreatown Los Angeles, California, United States